Date: 11/9/2022 Form: 10-Q - Quarterly Report
Download Pdf document  Download Word document  Download Excel tables  Download XBRL files (zip)  HTML version Print Zoom in Zoom out
v3.22.2.2
Cover - shares
9 Months Ended
Sep. 30, 2022
Nov. 15, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2022  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41159  
Entity Registrant Name IMMIX BIOPHARMA, INC.  
Entity Central Index Key 0001873835  
Entity Tax Identification Number 45-4869378  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 11400 West Olympic Blvd.  
Entity Address, Address Line Two Suite 200  
Entity Address, City or Town Los Angeles  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 90064  
City Area Code (310)  
Local Phone Number 651-8041  
Title of 12(b) Security Common stock, $0.0001 par value  
Trading Symbol IMMX  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   13,927,067